APA (7th ed.) Citation

Kraft, C. S., Sims, M., Silverman, M., Louie, T. J., Feuerstadt, P., Huang, E. S., . . . Memisoglu, A. (2024). Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI. Infectious Diseases & Therapy, 13(10), 2105. https://doi.org/10.1007/s40121-024-01007-z

Chicago Style (17th ed.) Citation

Kraft, Colleen S., et al. "Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI." Infectious Diseases & Therapy 13, no. 10 (2024): 2105. https://doi.org/10.1007/s40121-024-01007-z.

MLA (9th ed.) Citation

Kraft, Colleen S., et al. "Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI." Infectious Diseases & Therapy, vol. 13, no. 10, 2024, p. 2105, https://doi.org/10.1007/s40121-024-01007-z.